What is the best approach to manage a patient with type 2 diabetes mellitus, essential hypertension, and mixed hyperlipidemia presenting with blackouts, dizziness, and vision disturbances?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Urgent Ophthalmologic Evaluation and Comprehensive Workup Required

This patient requires urgent referral to ophthalmology within 1 month for dilated fundoscopic examination to evaluate for diabetic retinopathy, given his visual symptoms of "seeing stars" in one eye, which may indicate proliferative diabetic retinopathy or other vision-threatening complications. 1

Immediate Ophthalmologic Assessment

  • Urgent ophthalmology referral is mandatory for any patient with diabetes presenting with visual disturbances, as this may represent center-involving diabetic macular edema, proliferative diabetic retinopathy, or vitreous hemorrhage 1
  • The visual symptom of "seeing stars" (photopsia) combined with his 2-month duration warrants evaluation within less than 1 month per international guidelines for suspected severe nonproliferative or proliferative diabetic retinopathy 1
  • Annual dilated comprehensive eye examinations should have been performed starting at diagnosis for all type 2 diabetes patients, and this patient's visual symptoms indicate he may have missed critical screening 2

Essential Laboratory Testing

Order the following labs immediately:

  • Hemoglobin A1c to assess glycemic control over the past 3 months, with target <7% 2, 3
  • Comprehensive metabolic panel including serum creatinine and eGFR to evaluate renal function (critical before adjusting metformin dose and to assess for diabetic nephropathy) 3
  • Fasting lipid panel to verify LDL is at goal <100 mg/dL given his cardiovascular risk 2
  • Complete blood count to evaluate for anemia (which can cause dizziness) and rule out hematologic abnormalities 4
  • Serum glucose to assess for hypoglycemia or severe hyperglycemia as potential causes of his symptoms 1
  • Thyroid stimulating hormone (TSH) as thyroid dysfunction can cause dizziness and is more common in diabetics 5, 6
  • Vitamin B12 level given his metformin use, as deficiency can cause neuropathy and dizziness 1

Cardiovascular and Neurologic Evaluation

The combination of blackouts and dizziness requires systematic evaluation:

  • Orthostatic vital signs (blood pressure and heart rate supine and after 1-3 minutes standing) to evaluate for orthostatic hypotension, which is common with his antihypertensive regimen and may indicate autonomic neuropathy 1, 7
  • 12-lead electrocardiogram to evaluate for arrhythmias (atrial fibrillation, bradycardia, heart block) that could cause syncope 8, 7
  • Detailed history using timing and triggers approach: Determine if episodes are spontaneous vs. triggered, duration, associated symptoms, and whether true loss of consciousness occurs vs. near-syncope 7
  • Cardiovascular examination focusing on heart rhythm, murmurs, and carotid bruits given his multiple cardiovascular risk factors 7

Critical Medication Review

His current antihypertensive regimen may be excessive:

  • He is on triple antihypertensive therapy (amlodipine 10 mg, hydrochlorothiazide 25 mg, lisinopril 40 mg), which increases risk of orthostatic hypotension and syncope 4, 9
  • Amlodipine can cause dizziness (3.4% incidence at 10 mg dose) and peripheral edema (10.8% at 10 mg), and these side effects are more common in patients on multiple antihypertensives 4
  • Check blood pressure control: Target is <130/80 mmHg per current guidelines, but overtreatment causing hypotension may explain his symptoms 2, 9

Evaluate for hypoglycemia risk:

  • He is on triple diabetes therapy (glipizide ER 10 mg, Basaglar 15 units daily, pioglitazone 30 mg, metformin 750 mg BID), placing him at significant hypoglycemia risk 1, 3
  • Glipizide (sulfonylurea) is a major hypoglycemia risk, especially in combination with basal insulin 1
  • Review his home glucose log to identify patterns of hypoglycemia that could cause blackouts and dizziness 3

Diabetic Neuropathy Assessment

Screen for autonomic and peripheral neuropathy:

  • 10-gram monofilament testing of both feet to assess for diabetic peripheral neuropathy 1
  • Assess for symptoms of autonomic neuropathy: gastroparesis, erectile dysfunction, bladder dysfunction, and cardiovascular autonomic neuropathy (resting tachycardia, exercise intolerance) 1
  • Autonomic neuropathy can cause orthostatic hypotension and dizziness independent of medication effects 1

Vestibular Examination

If cardiovascular and metabolic causes are excluded:

  • Dix-Hallpike maneuver to evaluate for benign paroxysmal positional vertigo if dizziness is triggered by head movements 7
  • HINTS examination (Head Impulse, Nystagmus, Test of Skew) if acute vestibular syndrome is suspected, though this is less likely given the 2-month duration 7
  • However, the visual symptoms ("seeing stars") make ophthalmologic pathology more likely than primary vestibular disease 5, 6

Blood Pressure Optimization Strategy

Given his symptoms and medication burden:

  • Target blood pressure should be <130/80 mmHg, but avoid overtreatment causing symptomatic hypotension 2
  • Consider reducing or discontinuing hydrochlorothiazide if blood pressure is at goal and orthostatic hypotension is present 9
  • Lowering blood pressure decreases diabetic retinopathy progression, but strict goals (systolic <120 mmHg) provide no additional benefit and increase adverse effects 1

Glycemic Control Assessment

His complex diabetes regimen requires optimization:

  • Perform A1C testing quarterly since his therapy includes insulin and he may not be meeting glycemic goals 3
  • If A1C is ≥9%, he may benefit from insulin intensification rather than multiple oral agents 1
  • Metformin should be continued as long as eGFR ≥30 mL/min/1.73 m² and is the preferred agent 3
  • Consider discontinuing or reducing glipizide if hypoglycemia is documented, as sulfonylureas have high hypoglycemia risk with minimal cardiovascular benefit 1

Common Pitfalls to Avoid

  • Do not attribute visual symptoms to "floaters" or benign causes without dilated fundoscopic examination—this patient has multiple risk factors for proliferative diabetic retinopathy 1
  • Do not order brain MRI as first-line testing for dizziness without completing cardiovascular and metabolic evaluation first, as these are more common causes in diabetic patients 5, 7
  • Do not assume blackouts are seizures without considering cardiac syncope, hypoglycemia, and orthostatic hypotension first—the history is the most important diagnostic tool 8
  • Do not continue aggressive blood pressure lowering if orthostatic hypotension is present, as this increases fall risk and does not provide additional retinopathy benefit below 130/80 mmHg 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Preventing Diabetic Retinopathy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diabetes Management Guideline

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The evaluation of a patient with dizziness.

Neurology. Clinical practice, 2011

Research

Diagnosing and treating dizziness.

The Medical clinics of North America, 2014

Research

A New Diagnostic Approach to the Adult Patient with Acute Dizziness.

The Journal of emergency medicine, 2018

Research

Diabetes mellitus and hypertension.

Hypertension (Dallas, Tex. : 1979), 1992

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.